SynAct Pharma AB Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan '26 Jan 21, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	105	36	28	217	360	108
Market Cap Growth	140.11%	28.73%	-86.97%	-39.77%	234.62%	849.17%
Enterprise Value	98	33	26	212	356	105
Last Close Price	1.92	0.76	0.69	6.95	16.75	-
PB Ratio	5.96	1.95	1.78	19.10	177.45	68.14
P/TBV Ratio	5.96	1.95	1.78	19.10	177.45	68.14
Debt / Equity Ratio	0.01	0.01	0.00	0.02	0.15	-
Quick Ratio	3.18	2.66	3.00	8.19	2.25	3.67
Current Ratio	3.28	3.30	3.01	9.34	2.27	3.73
Return on Equity (ROE)	-58.39%	-42.22%	-142.59%	-134.62%	-377.30%	-189.27%
Return on Assets (ROA)	-30.35%	-22.48%	-50.54%	-72.92%	-159.60%	-82.32%
Return on Capital Employed (ROCE)	-51.40%	-37.00%	-73.80%	-82.70%	-333.20%	-197.20%
Earnings Yield	-9.15%	-19.77%	-68.71%	-4.11%	-1.87%	-2.46%
Buyback Yield / Dilution	-27.46%	-21.81%	-17.90%	-6.72%	-19.95%	-43.06%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.